Symptomatic improvement in diabetic neuropathy after 12 months of therapy with zenarestat, an aldose reductase inhibitor

被引：0
|
作者：
Bril, V
Ng, E
Nwe, P
Gogov, S
Ngo, ML
Skandarajah, S
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2136
引用
收藏
页码：A518 / A519
页数：2
相关论文
共 50 条
  • [21] Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
    Sharma, S. R.
    Sharma, Nalini
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2008, 11 (04) : 231 - 235
  • [22] Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis
    Okamoto, H
    Nomura, M
    Nakaya, Y
    Uehara, K
    Saito, K
    Kimura, M
    Chikamori, K
    Ito, S
    INTERNAL MEDICINE, 2003, 42 (08) : 655 - 664
  • [23] Improvement of the diabetic neuropathy by picamilon and aldose reductase inhibitors.
    Kuchmerovskaya, TM
    Parchometc, PK
    Donchenko, GV
    Obrosova, YG
    Klimenko, AP
    Kuchmerovsky, NA
    Pakyrbayeva, LV
    Efimov, AS
    VOPROSY MEDITSINSKOI KHIMII, 1998, 44 (06): : 559 - 564
  • [24] CLINICAL-TRIAL OF AN ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY
    HANDELSMAN, DJ
    TURTLE, JR
    DIABETES, 1981, 30 (06) : 459 - 464
  • [25] Fiber-specific effects of the aldose reductase inhibitor zenarestat in mild human diabetic polyneuropathy.
    Greene, DA
    Arezzo, JC
    Brown, MB
    DIABETOLOGIA, 1997, 40 : 2190 - 2190
  • [26] THE EFFECT OF SMALL DOSE OF ALDOSE REDUCTASE INHIBITOR (SORBINIL) ON DIABETIC NEUROPATHY
    LEHTINEN, J
    HYVONEN, K
    KILPELAINEN, H
    UUSITUPA, M
    PUHAKAINEN, E
    PARTANEN, J
    RIEKKINEN, P
    ACTA NEUROLOGICA SCANDINAVICA, 1984, 69 : 198 - 199
  • [27] FURTHER CLINICAL-STUDIES WITH AN ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY
    VANGERVEN, JMA
    DIABETIC MEDICINE, 1993, 10 (05) : S35 - S38
  • [28] Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat
    Y. Kuzumoto
    S. Kusunoki
    N. Kato
    M. Kihara
    P. A. Low
    Diabetologia, 2006, 49
  • [29] ALDOSE REDUCTASE INHIBITION FOR DIABETIC NEUROPATHY
    ABRAHAM, RR
    ABRAHAM, RM
    WYNN, V
    LANCET, 1983, 2 (8356): : 969 - 969
  • [30] EXPERIMENTAL AND CLINICAL-TRIAL OF ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY
    HOTTA, N
    KAKUTA, H
    KIMURA, M
    FUKASAWA, H
    KOH, N
    TERASHIMA, H
    IIDA, M
    SAKAMOTO, N
    DIABETES, 1983, 32 : A98 - A98
12345